Overview
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2004-09-17. Active
82 1140 1108 0000 5937 0400 1025
82 1020 1068 0000 1502 0573 8036- 24 1140 1108 0000 5937 0400 1002
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 1.0MPLN 1,025,078 |
Public aid
10 public aid cases recorded, with a total value of $347,527.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 16, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $31,716$31,716 | Prezes Banku Gospodarstwa Krajowego | |
| Jun 2, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $44,668$44,668 | Prezes Banku Gospodarstwa Krajowego | |
| May 27, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $75,337$75,337 | Prezes Banku Gospodarstwa Krajowego |
Tenders
No recorded participation in tenders.
Trademarks
Efferta Pharma holds 12 active trademarks registered with the Polish Patent Office. The first mark was filed in 1995.
| Mark | Protected until | |
|---|---|---|
| EFFERTA PHARMA | Dec 1, 2035 | |
| ŁYŻECZKA WITAMIN(word) | Aug 5, 2034 | |
| Vitaspoon(word) | Jan 8, 2033 | |
| Fitstyle(word) | Aug 22, 2027 | |
| IRON PULS(word) | Feb 15, 2027 |
Authorized Representatives
Manner of representation
Two members of the management board acting jointly or a member of the management board acting jointly with a commercial proxy are authorized to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 10,458 | $141,247.97 | 50% | |
| 4,394 | $59,346.30 | 21.0078% | |
| 1,673 | $22,595.89 | 7.9987% | |
| 4,391 | $59,305.78 | 20.9935% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Global Pharma CmS.A. | $24,132,016.98 | globalpharma.pl | ||
| ALG Pharmasp. z o.o. | $16,237,368.88 | algpharma.pl | ||
| Laboratoria Naturysp. z o.o. | $13,931,403.39 | laboratorianatury.pl | ||
| Yangosp. z o.o. | $8,214,312.60 | yango.pl | ||
| Iodica Worldsp. z o.o. | $1,668,750.20 | iodica.pl | ||
| Instytut Urządzeń Ekstrakcyjnychsp. z o.o. | $243,885.18 | sfe.com.pl | ||
| PolimerP.S.A. | $0.00 | polimer.pl | ||
| LL Supplementssp. z o.o. | – | tru.com.pl | ||
| Neotabsp. z o.o. | – | neotab.pl | ||
| Synteris Labssp. z o.o. | – | synterislabs.pl |
FAQ
Last updated: 2026-10-07